| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000049255 |
| Receipt No. | R000056086 |
| Scientific Title | Cardiac MRI findings of heart failure with reduced ejection fraction: A meta-analysis |
| Date of disclosure of the study information | 2022/10/18 |
| Last modified on | 2022/10/18 (Ver. 1) |
| Basic information | ||
| Public title | Cardiac MRI findings of heart failure with reduced ejection fraction: A meta-analysis | |
| Acronym | Cardiac MRI findings of heart failure with reduced ejection fraction: A meta-analysis | |
| Scientific Title | Cardiac MRI findings of heart failure with reduced ejection fraction: A meta-analysis | |
| Scientific Title:Acronym | Cardiac MRI findings of heart failure with reduced ejection fraction: A meta-analysis | |
| Region |
|
|
| Condition | |||
| Condition | heart failure with reduced ejection fraction | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Although the cardiac MRI finding of heart failure with reduced ejection fraction (HFrEF) has been reported in previous studies, these findings's prevalence and clinical relevance are unclear. This meta-analysis will clarify the prevalence and prognostic value of CMR findings for HFrEF patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Prevalence of abnormalities of CMR findings and impact on the prognosis in HFrEF patients. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Heart failure with ejection fraction | |||
| Key exclusion criteria | N/A | |||
| Target sample size | ||||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University | ||||||
| Division name | Department of Diagnostic Radiology | ||||||
| Zip code | 236-0004 | ||||||
| Address | 3-9, Fukuura, Kanazawaku, Yokohama, Japan | ||||||
| TEL | 07026335766 | ||||||
| shingo.m12226@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University | ||||||
| Division name | Department of Diagnostic Radiology | ||||||
| Zip code | 236-0004 | ||||||
| Address | 3-9, Fukuura, Kanazawaku, Yokohama, Japan | ||||||
| TEL | 07026335766 | ||||||
| Homepage URL | |||||||
| shingo.m12226@gmail.com | |||||||
| Sponsor | |
| Institute | Yokohama City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | None |
| Address | None |
| Tel | None |
| None | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This meta-analysis will extract the prevalence of abnormalities in CMR findings or myocardial strain in HFrEF patients. In addition, we will integrate the hazard ratio of these findings for predicting adverse events. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056086 |